Progress in Vocal Fold Regenerative Biomaterials: An Immunological Perspective
Patrick T. Coburn, Xuan Li, Jianyu Li and 2 more
Advanced NanoBiomed Research · 2022
doi:10.1002/anbr.202100119 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Vocal folds are important to daily breathing, speech, and swallowing functions. Irreversible changes to the vocal fold mucosa, such as scarring and atrophy, require regenerative medicine approaches to promote controlled regrowth of the mucosa. Various biomaterial systems have been engineered with an emphasis on stimulating extracellular matrix production from local fibroblasts. Simultaneously, it is imperative to minimize the foreign body response and associated inflammation that can hinder biomaterial−tissue integration. Biomaterial designs have become increasingly focused on actively harnessing the immune system to accelerate and optimize tissue regeneration. An array of biomaterial parameters have been reported to effectively modulate local immune cells, such as macrophages, to initiate tissue repair and restore the function of the vocal folds. In this perspective article, the unique immunological profile of the vocal folds is first reviewed. Key physical and chemical biomaterial properties relevant to immunomodulation are then highlighted and discussed. A further examination of the physicochemical properties of recent vocal fold biomaterials follows to generate deeper insights into corresponding immune‐related outcomes. Finally, a perspective will be offered on the opportunity of integrating material‐driven immunomodulatory strategies into future vocal fold tissue engineering therapies.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.